LOGO

You are here: 

 



 

  • Photocure wins patent case against the US Patent and Trademark Office

    The US Federal Circuit Court of Appeals (CAFC) has upheld a lower court's decision stating that the United States Patent and Trademark Office's interpretation of the law when refusing Photocure's request for patent term extension was not reasonable.

    >> Read more12.05.10

  • Algeta selects new Board of Directors

    Dr. Judith Hemberger and Dr. Kapil Dhingra were elected to Algeta's Board of Directors as Non-executive Directors at the Company's annual general meeting held in Oslo on 22 April 2010.

    >> Read more28.04.10

  • Affitech signs strategic alliance with Russian partner

    Affitech A/S, the antibody medicines company, has entered into a research and development collaboration with LLC NTS Plus (Russia). Simultaneously, Trans Nova Investments Limited, with the key beneficiary being Mr Viktor Kharitonin, Chairman of Pharmstandard, has made an equity investment of €20.9m in Affitech.

    >> Read more22.04.10

  • European expert panel recommends Hexvix

    Despite considerable positive evidence, the use of Hexvix has historically differed widely from country to country and between clinics. European recommendations from a consensus group have now been published, which may make the use of Hexvix-guided fluorescence cystoscopy more unison in Europe.

    >> Read more22.04.10

  • Algeta kåret til årets nyskaper

     Næringslivets Hovedorganisasjon i Oslo og Akershus har kåret legemiddelselskapet Algeta til vinner av NHOs nyskapingspris i 2010.

    >> Read more19.04.10

  • Norsk Biotekforum ber om ratifikasjon av London-avtalen

     Norsk Biotekforum oppfordrer næringsminister Trond Giske (bildet) til å fremme forslag om ratifikasjon av London-avtalen så snart som mulig. Avtalen begrenser oversettelseskravene ved søknad om patenter, og en ratifikasjon vil ikke koste Norge noe. Det vil samtidig være med på å skape et mer konkurransedyktig europeisk patentsystem, og bidra til at ressurser allokeres til andre viktige oppgaver i Norge.

    >> Read more15.04.10

  • Aker BioMarine signs major agreement

    Aker BioMarine has signed a major agreement with a leading European manufacturer and brand of dietary supplements. In the five year agreement Aker BioMarine will be the exclusive supplier of Superba™ Krill to the customer. The customer will formulate Superba™ Krill oil into one of its existing products and thus will purchase significant volumes immediately.

    >> Read more09.04.10

  • NorDiag completes certification process

    NorDiag has announced that the necessary clinical documentation for CE IVD labeling are in place and that the UL certification process has been completed, NorDiags Arrow instrument is therefore  available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical laboratories in Europe will now be able to use the instrument for clinical purposes.

    >> Read more09.04.10

  • Marine Biochemicals planning for growth

    Marine Biochemicals has defined a new organization that enables the company to accommodate for new growth over the years to come.

    >> Read more17.03.10

  • Svein Lien new CEO of Biotec Pharmacon ASA

    Svein Lien has been appointed new CEO of Biotec Pharmacon, following Lars Viksmoen's decision to resign after 3 years as CEO. Svein Lien will assume the position with effect from 15 March, 2010.

    >> Read more10.03.10

Showing from 11 to 20 of total 80 articles

Norwegian Bioindustry Association

Middelthuns gt. 27, Postboks 7072 Majorstuen, NO-0306 Oslo Tel: +47 23 08 88 00 / +47 23 08 88 18 / +47 91 10 54 91 Email: biotek@norskindustri.no Fax: +47 23 08 88 98